Results 191 to 200 of about 9,514 (200)

DNA HYPOMETHYLATING AGENTS FOR CANCER THERAPY

2015
MAIO MICHELE, COVRE ALESSIA, CORAL SANDRA   +2 more
openaire   +4 more sources

When is the optimal timing for allogeneic transplantation in the case of MDS patients treated with hypomethylating agents?

Expert Review of Hematology, 2013
Sang Kyun, Joon Ho Moon
exaly  

Methods for determining response to a hypomethylating agent

2014
BEJAR RAFAEL, EBERT BENJAMIN, NEUBERG DONNA, STEVENSON KRISTEN   +3 more
openaire   +2 more sources

Results of Treatment With Hypomethylating Agents Versus Hypomethylating Agents/Venetoclax in Patients With AML Single-Center Experience

Clinical Lymphoma Myeloma and Leukemia
Ana Flavia Patiño, Erika Brulc, Alberto Gimenez Conca   +2 more
openaire   +1 more source

Hypomethylating agents in myelodysplastic syndromes.

Clinical advances in hematology & oncology : H&O, 2012
openaire   +1 more source

HYPOMETHYLATING AGENTS FOR USE IN TREATMENT OF CANCER

2020
AZAB MOHAMMAD, HAO YONG, KEER HAROLD
openaire   +1 more source

Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia

Antoine Saliba, Scott Kaufmann, Saliba Antoine N   +2 more
exaly  

DNA HYPOMETHYLATING AGENTS FOR CANCER THERAPY

2014
MAIO MICHELE, COVRE ALESSIA
openaire   +1 more source

SYK INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS

2018
ABELLA ESTEBAN M, MARCONDES ANTONIO MARIO QUERIDO, RAO ARATI V   +2 more
openaire   +1 more source

Administration of a NEDD8-activating enzyme inhibitor and hypomethylating agent

2014
openaire   +4 more sources